O'Melveny
We only have limited information for this firm. Consider the following firms which have provided more information:
O'Melveny‘s corporate and M&A practice in China covers private and public M&A, joint ventures, growth investments and leveraged acquisitions. Other areas of strength are private equity buyouts, going-private transactions, carve-outs and spin-offs. The team is particularly sought out by biopharma and biotech companies for both inbound and outbound investments, while its sector expertise extends to real estate, automotive, entertainment and TMT. Walker Wallace is Shanghai office managing partner, and Ke Geng heads up the firm’s Beijing office.
Legal 500 Editorial commentary
Key clients
- Acotec Scientific
- Lazada and Alibaba
Abbreviated data is displayed for this firm.
Work highlights
- Advised Acotec Scientific Holdings Limited on a voluntary partial offer by Boston Scientific Group.
- Advised Lazada, a subsidiary of Alibaba Group Holding, on its $375m equity investment in PT Elang Andalan Nusantara.
Abbreviated data is displayed for this firm.